China intraocular lens market to grow at 2% CAGR through 2033, forecasts GlobalData
As myopia rates rise, China's intraocular lens market is poised for growth, driven by the need for long-term, effective vision correction solutions
The increasing prevalence of myopia, particularly in high-degree cases, is becoming a significant public health concern. Severe myopia not only impairs vision but also affects daily functioning and productivity. While glasses and contact lenses are widely used, they often provide limited correction, cause discomfort, and lack permanence. These limitations highlight the growing need for advanced, long-term solutions that can effectively address the visual challenges posed by severe myopia. Against this backdrop, China intraocular lens market is set to grow at a 2 per cent compound annual growth rate (CAGR) during 2024-33, according to GlobalData.
GlobalData’s latest report “China Intraocular Lens (IOL) Market Size (Value, Volume, ASP) by Segments, and Forecast, 2015-2033” reveals that China accounted for about 25 per cent of the Asia-Pacific (APAC) intraocular lens market in 2024, highlighting the growing demand for precise, long-term vision correction solutions.
Kanchan Chauhan, Medical Devices Analyst at GlobalData, comments, “As myopia rates continue to climb, particularly among patients with high refractive errors, the limitations of traditional corrective methods become increasingly evident. There is a critical need for effective options that provide lasting improvements in visual clarity and stability, particularly for individuals with high myopia.”
Eyebright Medical Technology. has recently received the Class III Medical Devices Certificate from the National Medical Products Administration (NMPA) for its Loong Crystal PR Phakic Intraocular Lens. This certification affirms the lens’s safety and efficacy in treating myopia in adults with refractive errors between -3.25D and -18.00D.
The Loong Crystal PR lens is made from advanced, balanced acrylic material, designed with zero spherical aberration, and features a stable double concave arch structure. These design elements optimize optical performance and ensure greater stability, resulting in excellent postoperative results for patients with severe myopia.
Chauhan concludes, “The development of innovative intraocular lenses highlights China’s dedication in advancing its ophthalmology sector. As the prevalence of conditions such as myopia, dry eye, and glaucoma increases, the demand for durable and effective solutions grows. With patients becoming more involved in their treatment decisions, there is significant potential for new, consumer-centric approaches to emerge, further strengthening China’s global reputation in providing high-quality healthcare solutions.”
- Advertisement -